Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion

被引：0
|
作者：
Akinobu Kurita
Shoichi Kado
Norimasa Kaneda
Masaharu Onoue
Shusuke Hashimoto
Teruo Yokokura
机构：
[1] Yakult Central Institute for Microbiological Research,
来源：
Cancer Chemotherapy and Pharmacology | 2003年 / 52卷
关键词：
Irinotecan hydrochloride; CPT-11; SN-38; Myelosuppression; Acute diarrhea; Delayed-onset diarrhea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：349 / 360
页数：11
相关论文
共 50 条
  • [1] Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion
    Kurita, A
    Kado, S
    Kaneda, N
    Onoue, M
    Hashimoto, S
    Yokoura, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (05) : 349 - 360
  • [2] Nursing management of irinotecan (CPT-11) induced side-effects
    Buda, P
    Arosti, O
    Bevegni, A
    Pisani, R
    Iacono, G
    Da Chà, M
    Tudisco, R
    Zappardino, A
    Inghilleri, A
    Carpanelli, I
    Visone, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S41 - S41
  • [3] Synthesis of CPT-11 (irinotecan hydrochloride trihydrate)
    Sawada, S
    Yokokura, T
    Miyasaka, T
    CAMPTOTHECINS: FROM DISCOVERY TO THE PATIENT, 1996, 803 : 13 - 28
  • [4] Irinotecan Hydrochloride (CPT-11) in Dialysis Patients with Gastrointestinal Cancer
    Ashizawa, Tatsuto
    Iwahori, Tohru
    Yokoyama, Takayoshi
    Kihara, Yuu
    Konnno, Osamu
    Jyojima, Yoshimaro
    Akashi, Isao
    Nakamura, Yuuki
    Hama, Kouichirou
    Iwamoto, Hitoshi
    Segawa, Mai
    Takeuchi, Hironori
    Hirano, Toshihiko
    Nagao, Takeshi
    ACTA MEDICA OKAYAMA, 2010, 64 (01) : 19 - 26
  • [5] Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea
    K. Takasuna
    T. Hagiwara
    K. Watanabe
    S. Onose
    S. Yoshida
    E. Kumazawa
    E. Nagai
    T. Kamataki
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 494 - 503
  • [6] Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea
    Takasuna, K.
    Hagiwara, T.
    Watanabe, K.
    Onose, S.
    Yoshida, S.
    Kumazawa, E.
    Nagai, E.
    Kamataki, T.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 494 - 503
  • [7] Clinical usefulness of oral granisetron hydrochloride for alleviation of delayed nausea and vomiting induced by CPT-11
    Ikeda, M
    Yasui, M
    Fukunaga, H
    Seshimo, I
    Takayama, O
    Ikenaga, M
    Yamamoto, H
    Ohue, M
    Sekimoto, M
    Monden, M
    EUROPEAN JOURNAL OF CANCER CARE, 2005, 14 (05) : 435 - 439
  • [8] Intermittent, repetitive administrations of irinotecan (CPT-11) reduces its side-effects
    Fujii, H
    Koshiyama, M
    Konishi, M
    Yoshida, M
    Tauchi, K
    CANCER DETECTION AND PREVENTION, 2002, 26 (03): : 210 - 212
  • [9] Irinotecan (CPT-11) for multiple myeloma
    Yano, H.
    Iida, S.
    Kayukawa, S.
    Nakagawa, C.
    Oguri, T.
    Ri, M.
    Inagaki, A.
    Sanda, T.
    Kusumoto, S.
    Ishida, T.
    Komatsu, H.
    Suzuki, A.
    Ueda, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 140 - 140
  • [10] Clinical pharmacogenetics of irinotecan (CPT-11)
    Ando, Y
    Hasegawa, Y
    DRUG METABOLISM REVIEWS, 2005, 37 (03) : 565 - 574
12345